Cargando…

Long-term outcomes of intravitreal activated protein C injection for ischemic central retinal vein occlusion: an extension trial

PURPOSE: Our previous 1-year pilot study evaluated the efficacy of intravitreally injected activated protein C (APC) in 10 eyes with ischemic central retinal vein occlusion (CRVO). The reperfusion of the areas of retinal nonperfusion (RNP) exceeded 50% of the baseline in five (50%) eyes 1 year after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hara, Chikako, Kamei, Motohiro, Sakaguchi, Hirokazu, Matsumura, Nagakazu, Sakimoto, Susumu, Suzuki, Mihoko, Nishida, Kentaro, Fukushima, Yoko, Nishida, Kohji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Retinal Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478745/ https://www.ncbi.nlm.nih.gov/pubmed/33893866 http://dx.doi.org/10.1007/s00417-021-05072-9

Ejemplares similares

Direct photocoagulation to leakage points to treat chronic macular edema associated with branch retinal vein occlusion: a pilot study
por: Sakimoto, Susumu, et al.
Publicado: (2014)

Relationship between grades of macular perfusion and foveal thickness in branch retinal vein occlusion
por: Sakimoto, Susumu, et al.
Publicado: (2013)

Suppression and Regression of Choroidal Neovascularization in Mice by a Novel CCR2 Antagonist, INCB3344
por: Xie, Ping, et al.
Publicado: (2011)

The Caliber of Optociliary Shunt Vessels Is Associated with Macular Blood Flow and Visual Acuity in Central Retinal Vein Occlusion
por: Kanai, Masanori, et al.
Publicado: (2021)

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)

Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial
por: Eter, Nicole, et al.
Publicado: (2016)

Microvascular Changes in the Cystic Lesion of Branch Retinal Vein Occlusion Imaged by Swept-Source Optical Coherence Tomography Angiography
por: Araki, Satoko, et al.
Publicado: (2022)

Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
por: Korobelnik, Jean-François, et al.
Publicado: (2016)

Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
por: Li, Xiaoxin, et al.
Publicado: (2017)

Matched control study of visual outcomes after arteriovenous sheathotomy for branch retinal vein occlusion
por: Yamane, Shin, et al.
Publicado: (2014)

Disease-modifying effects of ranibizumab for central retinal vein occlusion
por: Huang, Jason M., et al.
Publicado: (2021)

Vitrectomy without prone positioning for rhegmatogenous retinal detachments in eyes with inferior retinal breaks
por: Shiraki, Nobuhiko, et al.
Publicado: (2018)

The usefulness of the retinal sensitivity measurement with a microperimetry for predicting the visual prognosis of branch retinal vein occlusion with macular edema
por: Fujino, Ryosuke, et al.
Publicado: (2020)

Evaluation of non-exudative microcystoid macular abnormalities secondary to retinal vein occlusion
por: Francone, Anibal, et al.
Publicado: (2021)

Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
por: Kida, Teruyo, et al.
Publicado: (2021)

Rhegmatogenous retinal detachment following intravitreal ocriplasmin
por: Madi, Haifa A., et al.
Publicado: (2016)

Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion
por: Fortunato, Pina, et al.
Publicado: (2009)

Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
por: de Salles, Manuel Casselholm, et al.
Publicado: (2021)

Postponed care due to COVID-19 lockdown impact on visual acuity of retinal vein occlusion patients: a large cohort
por: Cohen, Ram, et al.
Publicado: (2022)

Commercially available rigid gas-permeable contact lens for protecting the cornea from drying during vitrectomy with a wide viewing system
por: Kamei, Motohiro, et al.
Publicado: (2012)

Relationship between Full-Thickness Macular Hole Onset and Posterior Vitreous Detachment: A Temporal Onset Theory
por: Sakaguchi, Hirokazu, et al.
Publicado: (2023)

Posterior vitreous detachment following intravitreal drug injection
por: Geck, Ulrich, et al.
Publicado: (2013)

Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye
por: Sugimoto, Masahiko, et al.
Publicado: (2017)

Treatment contentment and preference of patients undergoing intravitreal anti-VEGF therapy
por: Kellner, Ulrich, et al.
Publicado: (2021)

Correlation between change in central subfield thickness and change in visual acuity in macular edema due to retinal vein occlusion: post hoc analysis of COPERNICUS, GALILEO, and VIBRANT
por: Gu, Sophie Z., et al.
Publicado: (2022)

Intravitreal injection associated rhegmatogenous retinal detachment: outcomes of a European analysis
por: Vounotrypidis, Efstathios, et al.
Publicado: (2021)

Impact of intravitreal injection therapy on contrast sensitivity in patients with nAMD and DME
por: Dieke, Sebastian, et al.
Publicado: (2023)

Legal obligation in the general population: face mask influence on endophthalmitis after intravitreal injection
por: Neubauer, Jonas, et al.
Publicado: (2022)

Intravitreal dexamethasone: variation of surgical technique and prevention of ocular complications with ASOCT follow-up
por: Nuzzi, Raffaele, et al.
Publicado: (2022)

Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
por: Sugimoto, Masahiko, et al.
Publicado: (2022)

Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
por: Zirpel, Johanna J., et al.
Publicado: (2021)

Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
por: Hanhart, Joel, et al.
Publicado: (2022)

Low-Dose Lipopolysaccharide Pretreatment Suppresses Choroidal Neovascularization via IL-10 Induction
por: Matsumura, Nagakazu, et al.
Publicado: (2012)

Retinal Microvasculature and Visual Acuity after Intravitreal Aflibercept in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study
por: Busch, Caleb, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic’s first wave on the care and treatment situation of intravitreal injections in a German metropolitan region
por: Stemplewitz, Birthe, et al.
Publicado: (2022)

Ciliary body length revisited by anterior segment optical coherence tomography: implications for safe access to the pars plana for intravitreal injections
por: Lincke, Joel-Benjamin, et al.
Publicado: (2020)

The detrimental effects of delayed intravitreal anti-VEGF therapy for treating retinal pathology: lessons from a forced test-case
por: Navarrete, Ana, et al.
Publicado: (2022)

Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
por: Liu, Siyin, et al.
Publicado: (2022)

Retinal vascular occlusion and SARS-CoV-2 vaccination
por: Vujosevic, Stela, et al.
Publicado: (2022)

Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect”
por: Borrelli, Enrico, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mec47b2uq7u0uc3n458ks31otd